Therefore, targeting ASGR1 or its associated signaling axis holds promise as a novel strategy for controlling hepatic inflammatory responses and blocking macrophage polarization, and warrants further investigation in broader models of inflammatory liver disease. This evidence concerns the gene ASGR1 and liver disorder.